Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Optomed Plc Press Release 5 June 2025 at 10.30, Helsinki
Optomed Launches Next-Generation Handheld Fundus Camera to Power the Future of Oculomics in Everyday Healthcare
Optomed is proud to announce the launch of its latest innovation: Optomed Lumo®, a next-generation handheld fundus camera. Optomed Lumo delivers unmatched usability, accessibility, and adaptability - empowering health detection from the fundus, in any setting.
Oculomics, the emerging field focused on extracting health insights from the retina, is rapidly transforming preventive medicine. With this launch, Optomed is delivering on its vision to enable screening for all by equipping primary care clinics, community health centers, and non-specialist settings with the tools to easily detect early signs of systemic disease - right through the eye.
"With the slogan 'Capturing Health,' Optomed Lumo is more than just a fundus camera. It is a tool to unlock essential health data - quickly, accurately, and anywhere," comments Juho Himberg, CEO of Optomed. "Our new camera enables healthcare providers to detect and monitor systemic conditions earlier and more efficiently than ever before."
Non-mydriatic Optomed Lumo sets a new standard for efficiency in retinal diagnostics with its programmable workflows, intuitive user guidance and seamless integration into various medical workflows. Designed with input from healthcare professionals, this fundus camera offers intuitive operation with high-quality imaging and AI-enhanced diagnostic platforms, enabling faster decision-making.
"By expanding eye screening into primary care, we're opening up access to millions who might otherwise go undiagnosed," adds Laura Piila, Vice President of Devices at Optomed. "Optomed Lumo can be used both as a handheld and a desktop form, thus being the choice of any healthcare setting to become a gateway for systemic health insights."
Optomed Lumo is MDR Class IIa CE certified medical device. Initial deliveries are expected to begin in Q3 2025 in selected markets, with a broader rollout planned in subsequent quarters.
Optomed Plc
Further enquiries
Juho Himberg, CEO, juho.himberg@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company's products are sold via various sales channels in over 60 countries globally.